Filing Details
- Accession Number:
- 0000950170-24-039316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-01 16:08:42
- Reporting Period:
- 2024-03-28
- Accepted Time:
- 2024-04-01 16:08:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1888012 | Hillevax Inc. | HLVX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2007879 | Sean Mcloughlin | C/O Hillevax, Inc. 321 Harrison Ave, Suite 500 Boston MA 02118 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-28 | 1,250 | $16.98 | 1,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
